Drilon A, Subbiah V, Gautschi O, Tomasini P, et al. Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial. J Clin Oncol 2022 Sep 19:JCO2200393. doi: 10.1200/JCO.22.00393.
PMID: 36122315